Rewalk Robotics Ltd. (RWLK): John Vincent Hamilton , VP, Regulatory & Clinical of Rewalk Robotics Ltd. sold 329 shares on Jan 13, 2016. The Insider selling transaction was reported by the company on May 26, 2016 to the Securities and Exchange Commission. The shares were sold at $10.66 per share for a total value of $3,236.50 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 25, 2016, Jeff Dykan (director 10% owner) sold 1,400 shares at $8.98 per share price.On May 25, 2016, Wayne Weisman (director 10% owner) sold 1,400 shares at $8.98 per share price.
Rewalk Robotics Ltd (RWLK) witnessed a volatile trading activity on Wednesday May 25, 2016 and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $8.72 and reached the intraday high at $8.98. The bulls started the profit booking and pushed the shares to intraday low of $8.5001. The trading session was marked by a volume range of 83,287 shares exchanging hands. The 52-week high of the shares is $17.4 and the 52-week low is $5.55. The market cap of the company stands at $108 M and there are 1,23,71,415 shares in public circulation.
Rewalk Robotics Ltd is an Israel-based medical device company. The Company is engaged in designing developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company has developed and is continuing to commercialize ReWalk an exoskeleton that uses its patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. The Company offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk is a product that can fundamentally change the health and life experiences of users. ReWalk controls movement using subtle changes in the users center of gravity.